Related by context. All words. (Click for frequent words.) 71 HCV infection 70 chronic HBV 70 candidemia 69 Chronic lymphocytic leukemia 68 HBeAg negative 68 chronic HCV infection 68 hepatitis C genotype 68 hepatitis C HCV 67 chronic HCV 67 gastric adenocarcinoma 67 HCV infections 67 chronic hepatitis B. 67 nonmelanoma skin cancers 67 LTBI 67 hepatitis B HBV 66 cholangiocarcinoma 66 hepatitis B virus HBV 66 decompensated liver disease 66 posaconazole 66 HBeAg positive 66 cirrhosis liver failure 66 vWD 66 HBV infection 65 sJIA 65 basal cell carcinoma BCC 65 PCNSL 65 metastatic neuroendocrine tumors 65 ADPKD 65 chronic hepatitis cirrhosis 65 CMV disease 65 HeFH 65 seropositivity 65 chronic hepatitis B 65 P. falciparum malaria 64 SSc 64 invasive fungal infection 64 autoantibody positive 64 osteosarcomas 64 invasive candidiasis 64 parasitic worm infections 64 deletion 5q 64 relapsed leukemia 64 refractory gout 64 K ras mutations 64 hepatorenal syndrome 64 immunodeficiency 64 hepatocellular carcinoma HCC 64 Sebivo 64 fluoroquinolone resistance 64 NRTI resistance 64 elevated triglyceride levels 64 HER2 overexpression 64 relapsing remitting MS RRMS 64 gastric carcinoma 64 hepatitis B infection 64 prostate adenocarcinoma 64 secondary hyperparathyroidism 64 latent tuberculosis infection 64 juvenile idiopathic arthritis JIA 64 hypereosinophilic syndrome 64 AA amyloidosis 64 myeloproliferative neoplasms 64 null responder 64 skeletal metastases 64 pulmonary hypertension PH 64 H pylori 64 Gorlin syndrome 64 renal cell carcinomas 64 Velcade bortezomib 64 nonalcoholic steatohepatitis NASH 64 intracranial hemorrhage ICH 64 ABCB1 64 Myelodysplastic syndromes 64 CP CPPS 63 metastatic gastric 63 PAOD 63 Acute Bacterial Sinusitis ABS 63 Candida species 63 recurrent glioblastoma multiforme 63 C. trachomatis 63 SHPT 63 metastatic GIST 63 Lupus nephritis 63 oropharyngeal candidiasis 63 CCR5 tropic HIV 63 myelodysplastic myeloproliferative diseases 63 hypoparathyroidism 63 efalizumab 63 kidney urologic 63 chemotherapy induced neutropenia 63 Acute myeloid leukemia 63 VaD 63 relapsed MM 63 HIV coinfected 63 Staphylococcus aureus infections 63 sorafenib tablets 63 MGUS 63 HER2 expression 63 atrophic gastritis 63 NOMID 63 genital ulcer disease 63 calcineurin inhibitor 63 thalassemia sickle cell 63 latent TB infection 63 allogeneic bone marrow 63 invasive fungal infections 63 severe malignant osteopetrosis 63 carcinoid 63 chronic Hepatitis B 63 prostate cancer CaP 63 virus HCV infection 63 hepatocellular carcinomas 63 BCG refractory 63 histologic subtype 63 T2DM 63 CMV infection 63 e antigen HBeAg 63 Zavesca ® 63 hemorrhagic cystitis 63 hepatocellular cancer 63 mutated KRAS gene 63 advanced hepatocellular carcinoma 63 serotype #A 63 orchitis 63 clade B 63 allogeneic HSCT 63 cIAI 63 hematopoietic cancers 63 basiliximab 63 AAT deficiency 63 pancreatic insufficiency 63 dyslipidaemia 63 chronic ITP patients 63 systemic fungal infections 63 malignant neoplasms 63 leukemia CLL 63 Sudhir Agrawal D.Phil 63 tumor metastases 62 acute myelogenous leukemia AML 62 calcineurin inhibitors 62 HSV1 62 systemic scleroderma 62 pheochromocytoma 62 CMV retinitis 62 parasite Trypanosoma cruzi 62 S. aureus infections 62 nosocomial pneumonia 62 Severe Primary IGFD 62 candidiasis 62 BARACLUDE ® 62 Polycythemia vera 62 thrombocytopenic 62 epithelial tumors 62 ALT flares 62 recurrent genital herpes 62 Raptiva ® 62 TYZEKA 62 Pulmonary Arterial Hypertension PAH 62 nephrotoxicity 62 genital herpes infections 62 Aviptadil 62 esophageal candidiasis 62 Opportunistic infections 62 myeloproliferative 62 familial pancreatic cancer 62 alpha interferons 62 Candida infection 62 systemic lupus erythematosus SLE 62 diabetic kidney 62 Relapsing remitting MS 62 Hepatitis B virus 62 Sezary syndrome 62 intravenous bisphosphonates 62 posterior uveitis 62 papillary renal cell carcinoma 62 hypercholesterolaemia 62 tuberculin skin testing 62 ALI ARDS 62 S aureus 62 nonmetastatic 62 KRAS mutations occur 62 FLT3 mutations 62 acute GvHD 62 post herpetic neuralgia PHN 62 induced anemia 62 chronic GVHD 62 Clevudine 62 vaso occlusive crisis 62 symptomatic BPH 62 chronic periodontitis 62 NMIBC 62 follicular lymphoma FL 62 AA Amyloidosis 62 pancreatic neuroendocrine tumors 62 myeloproliferative diseases 62 TNF blocker therapy 62 Gleevec resistant 62 clinically evaluable 62 haematologic 62 Irritable bowel syndrome 62 MYH9 gene 62 hepatocellular carcinoma 62 severe rotavirus gastroenteritis 62 Plasmodium falciparum malaria 62 Tyzeka 62 Genital herpes 62 nasopharyngeal carcinoma 62 alemtuzumab treated 62 renal toxicity 62 myelofibrosis polycythemia vera 62 neurological manifestations 62 HBeAg positive patients 62 Gastric cancer 62 Ribavirin causes 62 Hepatitis C virus HCV 62 EBV infection 62 small lymphocytic lymphoma 62 Pulmonary arterial hypertension 62 gastric cancers 62 malignant pleural mesothelioma 62 grade cervical intraepithelial 62 herpesviruses 62 G6PD deficiency 62 Nonalcoholic fatty liver 62 varicella zoster virus VZV 62 HPV subtypes 62 non metastatic osteosarcoma 61 soft tissue sarcomas 61 KETEK 61 bacterial vaginosis BV 61 HCV genotype 61 HCV infected 61 common hematologic malignancy 61 chronic HCV genotype 61 external genital lesions 61 Salmonella typhi 61 combination antiretroviral therapy 61 falciparum 61 MALT lymphoma 61 lymphocytosis 61 Hepatocellular Carcinoma HCC 61 Kaposi sarcoma 61 elevated ALT 61 refractory multiple myeloma 61 immunosuppressed patients 61 hypercalcemia 61 Systemic lupus erythematosus SLE 61 Evoltra ® 61 oral squamous cell 61 TEAEs 61 malignant neoplasm 61 herpes zoster shingles 61 diabetic gastroparesis 61 pT3 61 Fanconi syndrome 61 proliferative disorders 61 rheumatologic 61 del 5q MDS 61 mRCC 61 HIV HCV coinfected 61 oropharyngeal candidiasis OPC 61 carcinoid tumors 61 octreotide LAR 61 CC genotype 61 interferon alfa 61 carcinoid syndrome 61 cystic fibrosis chronic pancreatitis 61 leukemia ALL 61 ABSSSI 61 idiopathic PAH 61 colorectal adenocarcinoma 61 rheumatoid arthritis Crohn disease 61 basal cell nevus syndrome 61 latent tuberculosis 61 neutropenia dehydration dyspnea 61 protozoal 61 atypical hemolytic uremic syndrome 61 immunocompetent 61 lupus scleroderma 61 primary immunodeficiency PI 61 immunodeficient 61 cisplatin chemotherapy 61 transplantation HCT 61 obstructive coronary artery 61 Clostridium difficile associated 61 Arranon 61 nucleoside analog 61 hepatoma 61 pancreatic NET 61 colorectal cancer CRC 61 smoldering multiple myeloma 61 hepatitis B immunoglobulin 61 Epstein Barr Virus EBV 61 essential thrombocythemia 61 poor metabolizers 61 asymptomatic carriers 61 BCR ABL mutations 61 selective modulator 61 seronegative 61 Recombinant interferon alpha 61 leukemia AML 61 multiple myeloma MM 61 minimally symptomatic 61 HBV 61 squamous cell lung cancer 61 chlamydial infection 61 adult chronic ITP 61 hyperphenylalaninemia HPA due 61 tumoral 61 proliferative diabetic retinopathy 61 Helicobacter pylori infection 61 vivax 61 chronic granulomatous disease 61 chlamydial infections 61 HCV genotype 1 61 erythema nodosum 61 unfavorable cytogenetics 61 IGFD 61 heterozygous FH 61 CYT# potent vascular disrupting 61 Raptiva R 61 neuroendocrine cancers 61 malignant pleural effusion 61 Atypical Hemolytic Uremic Syndrome 61 FluCAM arm 61 histological subtype 61 Chronic sinusitis 61 Aortic stenosis 61 mucosal inflammation 61 thalidomide Thalomid 61 terlipressin 61 tuberous sclerosis TS 61 FOLFIRI alone 61 HAV infection 61 Leukemias 61 HNSCC 61 completely resected 61 cytomegalovirus infection 61 cutaneous melanoma 61 invasive aspergillosis 61 Kepivance 61 cutaneous squamous cell carcinoma 61 breast carcinomas 61 herpes zoster virus 61 heavily pretreated 61 ano genital warts 61 Epstein Barr virus EBV 61 APTIVUS ritonavir 61 MDR tuberculosis 61 HbF 61 RhuDex ® 61 hyperprolactinemia 61 non Hodgkin lymphomas 61 atherothrombotic 61 micafungin 61 KRAS mutations 61 neovascular diseases 61 Toxicities 61 methicillin susceptible Staphylococcus aureus 61 mutated KRAS 61 Kit CD# positive 61 Azilect ® 61 atherothrombosis 61 idiopathic thrombocytopenic purpura ITP 61 piperacillin tazobactam 61 antiretroviral naive 61 isolated systolic hypertension 61 clinico pathological 61 BRAF V# mutation 61 familial ALS 61 Cryptococcus neoformans 61 S. aureus bacteremia 61 CCR5 receptor antagonist 61 stage IIIB 61 HBV infections 61 indolent NHL 61 Chronic myeloid leukemia 61 hepatic fibrosis 60 adenocarcinomas 60 subependymal giant cell 60 NNRTI resistance 60 rheumatoid arthritis psoriatic arthritis 60 docetaxel Taxotere ® 60 Squamous 60 transthyretin amyloidosis 60 chronic eosinophilic leukemia 60 H. influenzae 60 acute leukemias 60 cytopenias 60 Chlamydia trachomatis 60 anterior uveitis 60 Carcinoid tumors 60 lupus nephritis 60 diarrhea predominant irritable 60 EGFR inhibitors 60 varicella infection 60 mutated K ras 60 Amgen Neulasta R 60 Extensively drug 60 complement inhibitor eculizumab 60 tigecycline 60 pathologic myopia 60 severe hypersensitivity reactions 60 receiving XGEVA 60 antimuscarinic 60 cSSSIs 60 hematologic toxicity 60 hypercalcaemia 60 dacarbazine DTIC 60 Plaque psoriasis 60 Chlamydia pneumoniae 60 smoldering myeloma 60 interstitial pneumonia 60 toenail onychomycosis 60 chronic ITP 60 gonococcal 60 Chronic hepatitis B 60 TMP SMX 60 endocrine therapies 60 imatinib resistance 60 cutaneous T 60 treatment naïve genotype 60 HBV genotype 60 pharmacokinetic interactions 60 lymphadenopathy 60 cSSSI 60 situ CIS 60 neuroblastomas 60 HPAI H#N# 60 leukemia APL 60 coinfection 60 CCR5 tropic 60 primary hyperparathyroidism 60 acute respiratory tract infections 60 mecasermin 60 indinavir 60 TTR amyloidosis 60 multidrug resistance 60 pediatric acute lymphoblastic 60 voriconazole 60 breast endometrial 60 Infusion Reactions Severe 60 Candida infections 60 TREANDA 60 pegylated interferon alfa 60 malignant lymphomas 60 overactive bladder syndrome 60 lichen planus 60 thromboembolic events 60 IPAH 60 immune thrombocytopenic purpura 60 relapsed ovarian cancer 60 Plasmodium vivax 60 refractory Hodgkin 60 virus HBV 60 Fibrillex TM 60 Vaprisol 60 HBeAg negative patients 60 carcinoids 60 superficial bladder cancer 60 pamidronate 60 EGFR mutation positive 60 BCG refractory carcinoma 60 SCIg 60 glucocorticoid induced osteoporosis 60 Cholangiocarcinoma 60 Waldenstrom macroglobulinemia 60 chronic immune thrombocytopenic 60 malignant ascites 60 Bronchiectasis 60 microbiological eradication 60 PD LID 60 receptor tyrosine kinase inhibitor 60 haematopoietic 60 abacavir Ziagen 60 neutropenia thrombocytopenia 60 myeloproliferative disorders 60 chronic idiopathic urticaria 60 HBeAg 60 discontinued Viread 60 decompensated cirrhosis 60 neoplastic diseases 60 refractory chronic lymphocytic 60 PREZISTA r 60 thrombotic thrombocytopenic purpura TTP 60 CTAP# Capsules 60 clinically heterogeneous 60 MYLOTARG 60 immunomodulatory therapy 60 leukaemias 60 vinorelbine 60 Chronic Prostatitis 60 G#DT 60 Fludara ® 60 KRAS mutant tumors 60 gastrointestinal stromal tumors GISTs 60 acute rheumatic fever 60 neoplasias 60 leukopenia 60 mycoses 60 squamous cell histology 60 autoimmune thyroid 60 LHRH agonists 60 enterotoxigenic E. coli 60 pediatric Crohn disease 60 serum urate levels 60 Myelodysplastic syndromes MDS 60 ziconotide 60 GABHS 60 Behcet uveitis 60 mycosis fungoides 60 benign prostatic hypertrophy BPH 60 Pelvic inflammatory 60 sodium stibogluconate 60 Myelodysplastic Syndrome MDS 60 Tavocept 60 Tindamax R 60 AmBisome 60 cryptococcosis 60 IBS C 60 SPRYCEL ® 60 CCR5 antagonist 60 constipation OIC 60 lamivudine resistant 60 severe oral mucositis 60 HLA DRB1 * 60 EGFR mutations 60 Peginterferon alfa 2b 60 ARCALYST ® 60 gonococcal infections 60 Zinc deficiency 60 recurrent VTE 60 T1DM 60 leukoencephalopathy 60 viral hemorrhagic fevers 60 deep venous thromboses 60 TTR gene 60 metastatic bladder 60 EXJADE 60 GISTs 60 tumors GIST 60 postoperative ileus 60 hematological malignancy 60 VUR 60 malignant lymphoma 60 Soft Tissue Sarcoma 60 bacteraemia 60 chlamydial 60 novel VDA molecule 60 AEG# 60 cardiovascular cerebrovascular 60 metastatic RCC 60 immunocompromised patients 60 thyrotoxicosis 60 GH deficiency 60 Chronic myeloid leukemia CML 60 fibrotic disease 60 acute promyelocytic leukemia APL 60 Chronic pancreatitis 60 uveitis 60 hereditary predisposition 59 taxane chemotherapy 59 squamous cell carcinoma SCC 59 nonalcoholic steatohepatitis 59 Lubiprostone 59 Virulizin R 59 cervical intraepithelial neoplasia 59 genotypic resistance 59 SJIA 59 intestinal metaplasia 59 PREZISTA rtv 59 S. suis 59 BUPHENYL 59 BRAF V#E mutation 59 refractory CLL 59 anthracycline chemotherapy 59 gastric cancer 59 Acute Myeloid Leukaemia AML 59 Bcr Abl mutations 59 relapsing multiple sclerosis 59 bexarotene 59 oral vancomycin 59 neoplasm 59 refractory NSCLC 59 prostate carcinoma 59 MRSA isolates 59 immunosuppressive therapies 59 coinfected 59 arthritis PsA 59 APTIVUS r 59 parasitemia 59 hoFH 59 Idiopathic pulmonary fibrosis 59 colorectal carcinoma 59 Escherichia coli Klebsiella pneumoniae 59 urothelial carcinoma 59 unresectable tumors 59 Zavesca R 59 coagulation disorders 59 opioid induced constipation OIC 59 castrate resistant prostate cancer 59 peritumoral brain edema 59 M. leprae 59 HBeAg + 59 Salmonella Typhi 59 Primary IGFD 59 somatostatin analog 59 genotype 1b 59 transaminase levels 59 mildly symptomatic 59 Telbivudine 59 TNF antagonist 59 mediastinitis 59 fusion enhancers 59 replicon 59 relapsed multiple myeloma 59 effector function 59 HBsAg 59 hematologic disorders 59 mitochondrial toxicity 59 coagulation abnormalities 59 Vitamin B# deficiency 59 PNH patients 59 Vitamin D insufficiency 59 nucleoside analogs 59 NS5b 59 imipenem 59 dirucotide MBP# 59 alkylating agent 59 KRAS mutant 59 recombinant interferon 59 hepatic metastases 59 pyrexia mucositis sepsis febrile 59 EGFR mutation 59 PEGylated anti 59 lymphoid tumors 59 treatment naive genotype 59 precancerous cervical lesions 59 Hepatitis B Virus 59 chronic hepatitis 59 IgA deficiency 59 HCV 59 invasive fungal 59 anagrelide 59 adriamycin 59 forodesine 59 ankylosing spondylitis AS 59 tumor xenograft models 59 NSAID induced 59 GIST tumors 59 torsade de pointes 59 Papillary 59 gastrointestinal stromal tumor GIST 59 chronic idiopathic thrombocytopenic purpura 59 MAGE A3 ASCI 59 Trichomonas vaginalis 59 staphylococcal infections 59 HoFH 59 aplastic anemia AA 59 BMPR2 59 S. aureus infection 59 bacterium Neisseria meningitidis 59 Follicular lymphoma 59 Bacterial vaginosis 59 endophthalmitis 59 oesophageal adenocarcinoma 59 herpetic 59 sCJD 59 SNT-MC#/idebenone 59 diabetic nephropathy 59 pharmacologic intervention 59 metastatic malignant 59 vasogenic edema 59 Balamuthia 59 nephropathy 59 diffuse gastric 59 severe neutropenia 59 coinfections 59 VZV 59 Actimmune ® 59 lipohypertrophy 59 gouty arthritis 59 platelet dysfunction 59 nutlin 3a 59 N. gonorrhoeae 59 ZYVOX 59 systemic autoimmune 59 lupus erythematosus 59 transaminase elevations 59 pancreatic adenocarcinoma 59 astrocytomas 59 Plasmodium ovale 59 precursor lesions 59 CCR5 mAb 59 LCMV infection 59 endometrial ovarian 59 endometrial hyperplasia 59 nosocomial hospital 59 nucleoside analogues 59 Chronic lymphocytic leukemia CLL 59 Chronic HCV infection 59 pegylated interferons 59 malignant pleural mesothelioma MPM 59 Chlamydia trachomatis infection 59 familial adenomatous polyposis 59 chronic rhinosinusitis 59 Renal impairment 59 Chronic hepatitis C 59 postoperative delirium 59 Genetic susceptibility 59 bladder carcinoma 59 nitazoxanide 59 lipodystrophy 59 flutamide 59 beta interferons 59 Ixiaro 59 nitrofurantoin 59 familial amyloidotic polyneuropathy FAP 59 testicular germ cell 59 CMV infections 59 Human papillomavirus 59 Flu Cy 59 MRSA colonization 59 HCV genotypes 59 rFVIIa 59 CA MRSA infections 59 Plasmodium species 59 HNPCC 59 cytopathic 59 P aeruginosa 59 erlotinib Tarceva ® 59 hepatitis C virus HCV 59 urothelial bladder cancer 59 PROSTVAC VF 59 WNV infections 59 EGFR tyrosine kinase inhibitors 59 retinal vein occlusion 59 AGILECT R 59 breast carcinoma 59 antiplatelet medications 59 methicillin resistant S. aureus 59 arterial thrombosis 59 comparator arm 59 idiopathic thrombocytopenic purpura 59 nucleotide analog 59 HER2 positive cancers 59 lipid lowering agents 59 TEMODAL 59 immunopathology 59 cell lymphomas 59 elevated LDH 59 nucleoside analogue 59 CCR5 delta# 59 oral thrush 59 Virulizin ® 59 anogenital warts 59 debilitating autoimmune 59 imatinib mesylate 59 thromboembolic disease 59 nonnucleoside reverse transcriptase inhibitors 59 latent celiac disease 59 anemia hemoglobin 59 WNV infection 59 hyperuricemia 59 HIVAN 59 nonmelanoma 59 OHR/AVR# 59 RSV infections 59 de novo AML 59 metastatic carcinoid 59 Actinic Keratosis 59 Pneumocystis carinii pneumonia 59 uveal melanoma 59 anal HPV 59 hereditary deficiency 59 GBMs 59 interferon gamma 1b 59 bovine thrombin 59 Cx# [002] 59 serum leptin 59 variceal bleeding 59 HIV coinfection 59 Renal Cell Carcinoma RCC 59 Campath ® 59 oral candidiasis 59 dopaminergic therapy 59 subclinical disease 59 superficial basal cell carcinoma 59 CellCept mycophenolate mofetil 59 CHOP chemotherapy 59 hypermethylated 59 Chronic Lymphocytic Leukemia CLL 59 Streptococcus pneumoniae Haemophilus influenzae 59 castration resistant prostate cancer 59 Pseudomonas aeruginosa infections 59 SCCHN 59 systemically administered 59 interleukin IL -# 59 LHRH receptor positive 59 shingles herpes zoster 59 Respiratory Syncytial Virus RSV 59 neovascular glaucoma 59 bacteriuria 59 EoE 59 ADAMTS# 59 UGT#A# * 59 colorectal liver metastases 59 HBV vaccine 59 R5 tropic 59 T#I mutant 58 denileukin diftitox 58 Hepatitis C Virus HCV 58 TT genotype 58 serous ovarian cancer 58 noninfectious uveitis 58 Genasense ® 58 Proleukin 58 included exfoliative dermatitis 58 metastatic melanomas 58 dasatinib Sprycel 58 Sjögren syndrome 58 elevated IOP 58 Alzhemed TM 58 bronchoalveolar 58 human metapneumovirus 58 Vidaza azacitidine 58 follicular lymphomas 58 IMiDs ® compound 58 Certolizumab pegol 58 hepatitis C virus 58 invasive carcinomas 58 ZOLINZA 58 trastuzumab Herceptin ® 58 CIMZIA ™ 58 diabetes mellitus DM 58 galiximab 58 ovarian breast 58 MGd 58 SGPT 58 anti angiogenic agents 58 B7 H3 58 lymphoproliferative disease 58 chronic hepatitis C. 58 colon carcinoma 58 systemic juvenile idiopathic 58 gastrointestinal stromal tumors 58 liver metastases 58 thrombopoietin 58 overactive bladder OAB 58 Pathway Inhibitor 58 drugable targets 58 venous thromboembolic events 58 vidofludimus 58 choroidal neovascularization 58 Cancidas 58 Beta thalassemia 58 Hodgkin lymphoma HL 58 overt nephropathy 58 non splenectomized 58 Chronic Idiopathic Constipation 58 rs# [002] 58 GBA mutations 58 miglustat 58 T1c 58 degenerative retinal diseases 58 nontuberculous mycobacteria 58 thetreatment 58 Babesia 58 progressive neurodegenerative disorder 58 Lymphocytic 58 liver metastasis 58 thromboembolic complications 58 Herpes simplex virus 58 neurosyphilis 58 testicular tumors 58 chorioamnionitis 58 recurrent NSCLC 58 Elacytarabine 58 Interferon alpha 58 genital HSV 58 neutropenic patients 58 nonmelanoma skin cancer 58 cagA 58 Thrombocytopenia 58 Navelbine 58 metastatic renal cell carcinoma 58 asplenia 58 tumor histology 58 atopic disorders 58 motor neuron degeneration 58 colorectal adenoma 58 cytomegalovirus retinitis 58 Venous thromboembolism 58 herpes zoster 58 ß blockers 58 muscular dystrophy cystic fibrosis 58 granulomatous 58 Darinaparsin 58 ANCA associated 58 H. pylori eradication 58 pharyngitis tonsillitis 58 caspofungin 58 ribavirin therapy 58 clodronate 58 familial hypercholesterolemia 58 lymphocytic 58 diabetic neuropathic pain 58 SIMPONI TM 58 autonomic dysfunction 58 essential thrombocythemia ET 58 CIN3 58 demonstrated antitumor activity 58 juvenile idiopathic arthritis 58 abacavir lamivudine 58 recombinant hepatitis B 58 tipranavir ritonavir 58 atherothrombotic disease 58 HIV associated lipodystrophy 58 sulfasalazine 58 papillary carcinoma 58 arthralgias 58 microscopic hematuria 58 inherited mutations 58 TORISEL 58 transfusion transmitted 58 riociguat 58 enterovirus infection 58 CsA 58 BRCA1 mutation carriers 58 underlying vasculopathy 58 pulmonary metastases 58 unresectable HCC 58 Tamibarotene 58 refractory acute promyelocytic 58 oncogenic HPV 58 BCG vaccinated 58 empiric treatment 58 myopathy rhabdomyolysis 58 complete cytogenetic response 58 primary aldosteronism 58 Intravenous immunoglobulin 58 rheumatic disorders 58 biologic DMARD 58 C1 INH deficiency 58 metastatic malignant melanoma 58 relapsed AML 58 basal cell cancers 58 Noxafil 58 T#I mutation 58 CEQ# 58 pathophysiological effects 58 Torsades de Pointes 58 serum selenium 58 pancytopenia 58 CYP#C# [001] 58 atopic 58 liver transplantations 58 operable breast cancer 58 malignant pancreatic 58 treat chronic sinusitis 58 hypertriglyceridemia 58 Rheumatoid arthritis RA 58 erythropoietic 58 chronically infected 58 simplex virus 58 exocrine pancreatic insufficiency EPI 58 zidovudine AZT 58 visilizumab 58 lumiliximab 58 seropositive patients 58 FLT3 58 refractory cutaneous T 58 rotaviruses 58 advanced neoplasia 58 oral herpes 58 cranial irradiation 58 gastric atrophy 58 mesotheliomas 58 P. vivax malaria 58 mTOR inhibitors 58 Hp2 2 58 predominantly classic subfoveal 58 TNF alpha antagonist 58 Basal cell carcinoma 58 myopathies 58 JAK2 mutation 58 virus HCV 58 ceftazidime 58 UPLYSO 58 venous stasis ulcers 58 psoriatic arthritis PsA 58 AAT Deficiency 58 Malignant mesothelioma 58 amphotericin B 58 RRMS patients 58 CTEPH 58 Hurthle cell 58 chemoresistant 58 mixed dyslipidemia